Our technology is revolutionizing radiology. We’d love to work with you to help create better outcomes for patients everywhere.
The first FDA-cleared device that supports concurrent reading, allowing for faster reading with proven, superior, automatic nodule detection.
Our five FDA-cleared applications are designed to improve reading efficiency and accuracy across the hospital enterprise without additional equipment, procedures or radiation dose.
Riverain’s deep learning AI technology is FDA cleared, field tested, and clinically proven to provide real results in radiology.
Riverain Technologies advanced AI imaging software is in use by leading healthcare organizations around the world.
Peer reviews, reference accounts, and independent studies confirm that ClearRead technology is positively impacting the field of radiology.
Managing your lung program can seem daunting, whether you’re getting going, growing, or managing workflow. We’ve curated resources for you.
Miamisburg, Ohio, July 18, 2023 – Riverain Technologies, a medical device company revolutionizing chest imaging interpretation with Clear Visual Intelligence™ (CVI), achieved significant customer and partner growth and product milestones in the first half of 2023. Riverain’s ClearRead™ solutions with CVI are now being used by radiologists in 15 countries, including Japan, Switzerland, England, and the United States, to clearly, confidently, and quickly detect cardiothoracic diseases with newfound Certainty of Search™.
Significant milestones achieved by Riverain this year include:
“Strategically oriented healthcare organizations are looking for effective solutions to address the ever-increasing volume of imaging exams and the shortage of radiologists.” says Steve Worrell, CEO, Riverain Technologies. “Riverain is supporting this challenging environment based on proven ClearRead solutions with CVI, which aids radiologists in eliminating delayed cardiothoracic disease diagnoses, improving patient outcomes, and increasing image interpretation efficiency.”
ClearRead CT and ClearRead Xray allow radiologists to go beyond standard background-impaired imaging interpretation to remove interfering normal structures to create an unimpaired view of the chest. Utilizing the latest advances in deep learning, ClearRead solutions with Clear Visual Intelligence use unique suppression technology that integrates into chest X-rays and CT imaging interpretation.
With more than 4 million imaging exams now processed annually using ClearRead solutions, radiologists can focus on actionable data in chest imaging and improve diagnostic accuracy. ClearRead solutions with CVI are proven to reduce missed nodules by 29% and nodule search time by 26%.1
About Riverain Technologies
Riverain Technologies is on a mission to revolutionize radiology by eliminating delayed cardiothoracic disease diagnoses. Using a unique suppression technology, ClearRead solutions with CVI remove the interfering normal structures within the chest, like bones and vessels, and machine noise, which can compromise accurate and efficient diagnoses. This provides an unimpaired view that enables the radiologist to uniquely focus on the actionable data in chest imaging to precisely detect, characterize, and report findings to improve diagnostic accuracy and advance earlier intervention. For more information: https://www.riveraintech.com/.
|This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
|The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
|This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
|This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
|This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".